Affordability

Affordability

Affordability asks whether a person, household or payer can meet the cost of needed care without an unacceptable sacrifice of other necessities or priorities. The answer depends on whose resources and expenses are counted, when payment is due, and the relevant alternatives. This page distinguishes household and payer affordability, shows transparent measures, and explains why low prices, insurance coverage and favorable cost-effectiveness results do not by themselves establish affordability.

Specify who faces the payment

A patient may face premiums, copayments, deductibles, medicines, travel, lost earnings and informal caregiving costs; the relevant items depend on the question and perspective. A household with the same nominal bill as another may have much less income left for food and housing. A health service or insurer instead confronts a budget and an eligible population, while a society-wide appraisal asks what other uses of resources are displaced.

Perspective	Resources and costs to examine	Question the measure answers
Individual or household	Disposable income or consumption, essential needs, direct payments and other relevant access costs.	Can needed care be obtained without hardship or foregoing necessities?
Payer or programme	Available budget, expected number treated, net prices and delivery costs.	Can this coverage decision be financed over the stated period?
Health system	Staff, facilities, medicine supply and funding across services.	What services or capacity are displaced by the decision?

These perspectives are connected but not interchangeable. A manufacturer's rebate may improve a payer's spending without lowering the patient's charge if cost sharing is calculated from another price. A patient can face no direct charge yet be unable to afford travel or time away from work. Conversely, an insurer can finance a treatment by raising contributions or reducing other coverage, shifting rather than eliminating the burden.

Measure household burden with a declared denominator

One simple descriptive measure is household out-of-pocket health spending divided by household income or consumption during the same period. For global monitoring, catastrophic spending is often operationalized using a 10% or 25% share of total household consumption or income; alternative methods use capacity to pay after basic needs. These are indicator definitions, not universal moral thresholds for when any one household finds care affordable.

Suppose a fictional household has £24,000 annual consumption and £3,000 in direct out-of-pocket health payments over the same year. Its measured share is $£3{,}000/£24{,}000=0.125$, or 12.5%. Under a 10%-of-total-consumption definition it crosses the specified catastrophic-spending threshold; under a 25% definition it does not. Neither classification tells us whether the household borrowed, sold assets, missed treatment, or had enough left for necessities. If some care was forgone because of cost, spending alone understates the affordability problem.

Household calculation	Spreadsheet expression	Result
Out-of-pocket share	=3000/24000	12.5%.
Ten-percent threshold amount	=24000*10%	£2,400.
Amount above that threshold	=3000-2400	£600.

Compare like time periods and distinguish out-of-pocket payments from insured premiums or other spending according to the chosen indicator's definition. Household consumption and disposable income are different denominators. A subgroup analysis by income, geography or health status is often more informative than a single national average; report the measure, threshold, data source and missing spending explicitly.

Check payer affordability separately

A payer's affordability question concerns expected expenditure within a real budget. Suppose 600 eligible patients are expected to receive a medicine at an agreed net acquisition price of £8,000 per patient-year, plus £500,000 total administration and monitoring cost. Expected annual programme spending is $600\times£8{,}000+£500{,}000=£5{,}300{,}000$. If the relevant annual budget is £5 million, the illustrative funding gap is £300,000 under those assumptions.

That difference is a budget gap, not evidence that the medicine lacks health value. Eligibility, uptake, duration, rebates, taxes where relevant, and alternative care costs may change the estimate. Some costs may fall in a later year or another agency's budget. An economic evaluation may find an intervention offers good value over a lifetime while its first-year cash requirement exceeds available funds; a budget impact analysis should show the timing and the budget holder explicitly.

Connect affordability to access and financial protection

Observed utilization is an incomplete signal of affordability. A low out-of-pocket bill among people who used care can coexist with high unmet need among people priced out entirely. Combine spending data with questions about delayed or forgone care, borrowing, debt, and barriers such as travel or lack of leave. The OECD distinguishes reported unmet care due to cost, distance and waiting; affordability is specifically the financial part, though these barriers can interact.

Insurance can pool risk and reduce direct payment, but coverage limits, cost sharing and nonmedical expenses may leave people exposed. Financial protection addresses the risk that care spending causes hardship or impoverishment; it is closely connected to affordability but not identical to a quoted price or a payer's budget. An intervention that lowers patient charges may improve access and change use, so budget projections should not assume utilization remains fixed.

Use the result in a decision

Policy options include reducing patient charges, pooling funds, targeting subsidies, negotiating prices, changing the covered package or spreading implementation over time. Compare each option's distribution of benefits and burdens, feasible financing and opportunity costs. A fixed threshold can help monitoring but can miss a household just below it, a household facing repeated small payments or one with no spending because treatment was unaffordable.

In reporting, state the unit of analysis, currency and price year, income or budget denominator, included costs, horizon, population and threshold if one is applied. Keep affordability separate from cost-effectiveness: the latter compares incremental resources and health outcomes with alternatives, while the former asks whether particular actors can pay or absorb the spending under actual constraints. Both are relevant to a defensible decision.

Sources and further reading

• World Health Organization, “Financial protection,” for household financial hardship and alternative monitoring approaches: https://www.who.int/health-topics/financial-protection
• World Bank, UHC catastrophic out-of-pocket spending indicator metadata, for the 10% and 25% total income or consumption definitions: https://databank.worldbank.org/metadataglossary/health-nutrition-and-population-statistics/series/SH.UHC.OOPC.25.TO
• World Health Organization, “Universal health coverage,” for access without financial hardship: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)
• OECD, Health at a Glance 2025, unmet health care needs, distinguishing reported cost, distance and waiting barriers: https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/unmet-needs-for-healthcare_c994e8b1.html